We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
-1.13%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$6.91B
AUM Growth
-$595M
Cap. Flow
-$467M
Cap. Flow %
-6.76%
Top 10 Hldgs %
35.1%
Holding
109
New
3
Increased
13
Reduced
72
Closed
4

Top Sells

Rank Stock Value
1
ADNT icon
Adient
ADNT
+$77.2M
2
CNQ icon
Canadian Natural Resources
CNQ
+$36.3M
3
DKS icon
Dick's Sporting Goods
DKS
+$30.9M
4
CVE icon
Cenovus Energy
CVE
+$27.6M
5
TU icon
Telus
TU
+$27.4M

Sector Composition

Rank Sector Weight
1 Financials 28.74%
2 Energy 17.27%
3 Communication Services 15.86%
4 Materials 12.6%
5 Healthcare 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
101
Kimberly-Clark
KMB
$33B
$268K ﹤0.01%
2,025
RDS.B
102
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$262K ﹤0.01%
5,912
-2,000
-25% -$79.2K
ONCR
103
DELISTED
Oncorus, Inc.
ONCR
$231K ﹤0.01%
24,750
ARDX icon
104
Ardelyx
ARDX
$909M
$227K ﹤0.01%
172,300
BCEL
105
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$111K ﹤0.01%
17,800
ADNT icon
106
Adient
ADNT
$1.45B
-1,708,097
Closed -$77.2M
E icon
107
ENI
E
$80.6B
-13,000
Closed -$317K
MSFT icon
108
Microsoft
MSFT
$3.75T
-800
Closed -$217K
UNH icon
109
UnitedHealth
UNH
$344B
-1,850
Closed -$741K

Similar funds

Letko, Brosseau & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Letko, Brosseau & Associates held 109 positions worth $6.91B, down 7.9% from $7.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Letko, Brosseau & Associates withdrew a net $467M in Q3 2021, closing 4 positions and reducing 72 holdings. Its most notable exit was Adient, an estimated $77.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Energy and Communication Services.

Against the trend, Letko, Brosseau & Associates opened a new position in Bausch Health worth $32.5M.

  • Letko, Brosseau & Associates's largest Q3 2021 buy was Bausch Health: 1,164,200 shares worth $32.5M.
  • Letko, Brosseau & Associates added most to Macerich in Q3 2021, an estimated $13.1M increase.
  • Letko, Brosseau & Associates's biggest Q3 2021 reduction was Canadian Natural Resources, cutting an estimated $36.3M.
  • Letko, Brosseau & Associates fully exited Adient in Q3 2021, selling an estimated $77.2M.
  • Letko, Brosseau & Associates's ten largest holdings make up 35% of its $6.91B portfolio in Q3 2021.
  • Letko, Brosseau & Associates opened 3 new positions and closed 4 in Q3 2021.
  • Letko, Brosseau & Associates's portfolio value fell 7.9% quarter-over-quarter to $6.91B.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2021, filed 3 Nov 2021.